The DGFT has issued Public Notice No. 3/2023 dated April 03, 2023 extending the date for implementation of the Track and Trace system for the export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on the Central Portal till August 01, 2023 for both SSI and non SSI manufactured drugs.
In exercise of the powers conferred under Paragraph 2.04 of the Foreign Trade Policy, 2015-20, as amended from time to time, the Director General of Foreign Trade hereby amends Para 2.90A of Handbook of Procedure- 2015-20, as notified vide Public Notice No. 43/2015-20 dated December 05, 2017 read with Public Notice No. 52/2015-20 dated January 05, 2016, Public Notice No. 05/2015-20 dated May 09, 2018, Public Notice No. 43/2015- 2020 dated November 01, 2018, Public Notice No. 16/2015- 2020 dated July 04, 2019, Public Notice No. 66/2015- 2020 dated March 30, 2020, Public Notice No. 16/2015-2020 dated September 22, 2020, Public Notice No. 46/2015-20 dated March 30, 2021 and Public Notice No. 01/2015-2020 dated January 04, 2022 on laying down the procedure for implementation of the Track and Trace system for export consignments of drug formulations.
In Para 2.90 A (vi) and (vii) of Handbook of Procedure – 2015-20 (as amended vide Public Notice No. 01/2015-2020 dated January 04, 2022), “March 31, 2023″ may be substituted by August 01, 2023”.
Effect of this Public Notice:
The date for implementation of Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and its uploading on Central Portal has been extended upto August 01, 2023 for both SSI and non SSI manufactured drugs.
The Public Notice can be accessed at: https://content.dgft.gov.in/Website/dgftprod/36d4a717-7d18-4d9d-abfc-8e710a1cf801/Public%20Notice%20No.%2003%20dated%2003-04-2023-%20English.pdf